Los Angeles Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4M Sell
184,375
-3,941
-2% -$85.5K 0.02% 337
2025
Q1
$4.57M Sell
188,316
-15,708
-8% -$381K 0.02% 304
2024
Q4
$4.26M Buy
204,024
+3,742
+2% +$78.1K 0.02% 342
2024
Q3
$3.98M Buy
200,282
+123,020
+159% +$2.45M 0.02% 340
2024
Q2
$1.2M Sell
77,262
-3,755
-5% -$58.2K ﹤0.01% 599
2024
Q1
$1.29M Buy
81,017
+35,066
+76% +$559K ﹤0.01% 609
2023
Q4
$772K Sell
45,951
-41,330
-47% -$695K ﹤0.01% 757
2023
Q3
$1.02M Sell
87,281
-941
-1% -$11K ﹤0.01% 638
2023
Q2
$1.19M Sell
88,222
-21,951
-20% -$295K ﹤0.01% 615
2023
Q1
$1.83M Sell
110,173
-17,462
-14% -$290K 0.01% 517
2022
Q4
$2.37M Sell
127,635
-13,907
-10% -$259K 0.01% 478
2022
Q3
$1.82M Sell
141,542
-226,092
-61% -$2.9M 0.01% 524
2022
Q2
$2.58M Buy
367,634
+131,159
+55% +$919K 0.01% 472
2022
Q1
$1.96M Sell
236,475
-50,370
-18% -$417K 0.01% 538
2021
Q4
$1.94M Buy
286,845
+55,880
+24% +$378K 0.01% 523
2021
Q3
$1.22M Buy
230,965
+57,180
+33% +$303K 0.01% 677
2021
Q2
$999K Buy
+173,785
New +$999K ﹤0.01% 859
2021
Q1
Sell
-362,065
Closed -$1.21M 1591
2020
Q4
$1.21M Sell
362,065
-26,320
-7% -$87.9K 0.01% 852
2020
Q3
$1.15M Sell
388,385
-86,485
-18% -$257K 0.01% 769
2020
Q2
$2.19M Buy
474,870
+159,865
+51% +$739K 0.01% 594
2020
Q1
$1.21M Buy
315,005
+208,445
+196% +$803K 0.01% 664
2019
Q4
$400K Buy
106,560
+3,350
+3% +$12.6K ﹤0.01% 1064
2019
Q3
$548K Buy
103,210
+8,250
+9% +$43.8K ﹤0.01% 955
2019
Q2
$365K Buy
94,960
+52,260
+122% +$201K ﹤0.01% 1125
2019
Q1
$218K Hold
42,700
﹤0.01% 1285
2018
Q4
$82K Sell
42,700
-200
-0.5% -$384 ﹤0.01% 1244
2018
Q3
$162K Buy
42,900
+25,940
+153% +$98K ﹤0.01% 1353
2018
Q2
$53K Buy
+16,960
New +$53K ﹤0.01% 1424